Biofilms were grown on preconditioned voice prostheses with biosurfactants obtained from probiotic bacteria Lactococcus lactis 53 and Streptococcus thermophilus A in an artificial throat model. Both biosurfactants greatly reduced microbial numbers on prostheses and also induced a decrease in the airflow resistance that occurs on voice prostheses after biofilm formation. This study presents a promising strategy for prolonging the lifespan of voice prostheses.
Biofilms were grown on preconditioned voice prostheses with biosurfactants obtained from probiotic bacteria Lactococcus lactis 53 and Streptococcus thermophilus A in an artificial throat model. Both biosurfactants greatly reduced microbial numbers on prostheses and also induced a decrease in the airflow resistance that occurs on voice prostheses after biofilm formation. This study presents a promising strategy for prolonging the lifespan of voice prostheses.
Voice prostheses are used for speech rehabilitation of patients who have undergone a laryngectomy due to a malignant laryngeal tumor and need to breathe through a tracheostomy (1) . The major drawback of voice prostheses involves their colonization within several weeks by a thick biofilm that consists of fungal and bacterial strains. This biofilm causes leakage of food and liquid, and it may block the valves and increase resistance to airflow (10) , making it necessary to replace the prosthesis on average every 3 to 4 months. Prolonged administration of antifungal agents to patients is undesirable because of the danger of inducing resistance (7) . The use of biosurfactants from probiotic bacteria as antimicrobial and/or antiadhesive agents is promising as a method of prolonging the lifetimes of voice prostheses, and their ability to inhibit adhesion of various microorganisms isolated from explanted voice prostheses has been demonstrated in a study using parallel-plate flow chambers (11) .
The aim of the present study was to evaluate the extent of biofilm formation by a mixture of bacterial and fungal strains isolated from explanted voice prostheses and cultured on silicone rubber voice prostheses with an adsorbed biosurfactant layer. The two tested biosurfactants were obtained from the probiotic bacteria Lactococcus lactis 53 and Streptococcus thermophilus A. A microbial growth inhibition test was first performed in order to estimate the concentration of biosurfactant to be used in the artificial throat experiments. To this end, biofilms were grown on voice prostheses in an artificial throat model (9) . In addition to biofilm evaluation, the effects of biosurfactant adsorption to voice prostheses on resistance to airflow were determined.
The biosurfactant was isolated as previously described (2; L. Rodrigues ] to a concentration allowing confluent growth when plated with a cotton swab on the agar. Fungal strains were plated on De Man, Rogosa and Sharpe (MRS) agar (Merck), whereas bacteria were plated on brain heart infusion agar (Oxoid, Basingstoke, England). Agar plates were dried for 20 min at room temperature, and 5-l aliquots of biosurfactant 1 or 2 in several concentrations (3, 5, 10, 25, 50, and 100 mg ml Ϫ1 ) were spotted onto the surface of the agar plate. After overnight incubation, the agar plates were screened for growth inhibition zones around the biosurfactant spots.
Voice prostheses ("Low Resistance" Groningen button; Mé-din Instruments and Supplies, Groningen, The Netherlands) made of implant grade silicone rubber were placed in artificial throats (9) (Fig. 1 ). For experiments with the selected biosurfactants at concentrations of up to 100 mg ml Ϫ1 , artificial throats were autoclaved before use and equipped with one of three voice prostheses. One prosthesis was used as a control, and two prostheses were preconditioned overnight at 4°C with biosurfactant 1 or 2. To mimic the biofilms found in laryngectomized patients, the artificial throats were inoculated for 5 h with a combination of equal concentrations of the microbial strains listed in Table 1 (7) . After inoculation, the voice prostheses were incubated at 37°C to grow a biofilm during 3 days by filling the devices with growth medium each day [the medium consisted of a mixture of 30% brain heart infusion broth and 70% defined yeast extract medium containing, per liter, 7.5 g of glucose, 3.5 g of (NH 4 ) 2 SO 4 , 1.5 g of L-asparagine, 10 mg of L-histidine, 20 mg of DL-methionine, 20 mg of DL-tryptophan, 1 g of KH 2 PO 4 , 500 mg of MgSO 4 ⅐ 7H 2 O, 500 mg of NaCl, 500 mg of CaCl 2 ⅐ 2H 2 O, 100 mg of yeast extract, 500 g of H 3 BO 3 , 400 g of ZnSO 4 ⅐ 7H 2 O, 120 g of Fe(III)Cl 3 , 200 g of Na 2 MoO 4 ⅐ 2H 2 O, 100 g of KI, and 40 g of CuSO 4 ⅐ 5H 2 O]. From day 4 to day 7 the artificial throats were perfused three times a day with 250 ml of phosphate-buffered saline (PBS) (10 mM KH 2 PO 4 and K 2 HPO 4 and 150 mM NaCl with pH adjusted to 7.0). At the end of each day, the prostheses were filled with growth medium for half an hour and then placed overnight in the moist environment of the drained artificial throats (i.e., without any medium inside). Previously, this cycle of nutrients and no nutrients had been demonstrated as being essential to the growth of biofilms with features similar to those found on explanted prostheses (9) . All experiments were carried out in triplicate.
To measure airflow resistances, compressed air was blown through each voice prosthesis prior to biofilm formation and after coverage with a 7-day-old biofilm (6). The airflow resistances of individual voice prostheses prior to biofilm formation differed due to manufacturing. Therefore, all airflow resistances measured were expressed relative to the airflow resistance of the same prosthesis prior to biofilm formation.
On the eighth day of an experiment, the airflow resistances and the numbers of CFU on the voice prostheses with a biofilm were determined. Biofilms were removed by scraping, and the collected material was sonicated on ice for 10 s (the material was suspended in reduced transport fluid) and subsequently serially diluted. The sonication procedure did not promote cell lysis. After plating onto blood agar (blood agar from Oxoid supplemented with 5% sheep blood, 0.5% hemin, and 0.1% menadione) for isolation of bacterial strains and onto MRS agar for isolation of fungal strains, plates were incubated at 37°C in an aerobic incubator for 3 days. The numbers of bacterial and fungal CFU on each prosthesis were determined and expressed as percentages of the numbers of the control.
The antimicrobial activities of the biosurfactants, at several concentrations, to a variety of bacterial and fungal strains isolated from explanted voice prostheses were evaluated and compared ( Table 1 ). The two biosurfactants are antimicrobial agents but, depending on the microorganism, have different effective concentrations. It was found that both biosurfactants show a high antimicrobial activity against Candida tropicalis GB 9/9 even at low concentrations. At the highest concentration tested (100 mg ml Ϫ1 ), both biosurfactants were active against all bacterial and fungal strains involved in this study, except for Rothia dentocariosa GBJ52/2B, which formed some colonies within the biosurfactant spots. Elving et al. (5) recently demonstrated that R. dentocariosa was the most frequently isolated bacterial strain for a group of patients whose prostheses failed after a short time of use, making replacement necessary, which suggests that the organism may be associated with prosthetic failure. Therefore, the exclusion of this bacterial strain from the oral microflora by selected antibiotics or salivary peptides might well be more effective than the currently applied antimycotic regime, which has no proven clinical efficacy. From the results of the microbial growth inhibition test, a concentration of 100 mg ml Ϫ1 for each biosurfactant was chosen for preconditioning the voice prostheses.
Biosurfactants 1 and 2 decreased significantly the amount of bacteria in the biofilm, to 4 and 13% of the control, respectively (Table 2) . Biosurfactant 1 reduced the amount of fungal organisms to 15% of the control, whereas biosurfactant 2 reduced them to 26% of the control. According to the literature, the consumption of buttermilk, which contains antimycoticagent-releasing L. lactis, positively affects the lifetime of voice prostheses (3) . Moreover, the biosurfactants released by S. thermophilus interfere with the initial deposition of fungal strains onto silicone rubber (2), as well as on the formation of Staphylococcus epidermidis GB 9/6 Ϯ Ϯ ϩ ϩ ϩ Ϯ Ϯ Ϯ ϩ ϩ Streptococcus salivarius GB 24/9 Ϫ Ϫ Ϯ Ϯ ϩ Ϫ Ϫ Ϯ Ϯ ϩ Staphylococcus aureus GB 2/1 Ϯ Ϯ Ϯ ϩ ϩ Ϫ Ϫ Ϯ Ϯ ϩ Rothia dentocariosa GBJ 52/2B Ϫ Ϫ Ϯ Ϯ Ϯ Ϫ Ϫ Ϯ Ϯ Ϯ Candida albicans GBJ 13/4A Ϫ Ϯ Ϯ ϩ ϩ Ϫ Ϫ Ϯ ϩ ϩ Candida tropicalis GB 9/9 ϩ ϩ ϩ ϩ ϩ ϩ ϩ ϩ ϩ ϩ a ϩ, growth inhibition observed (no colonies formed); Ϯ, limited growth inhibition (some colonies formed); Ϫ, no growth inhibition (many colonies formed). b The numbers of bacterial and fungal CFU observed with the control were 6.7 ϫ 10 6 and 1.4 ϫ 10 5 per cm 2 , respectively, on the esophageal surface of the "Low Resistance" Groningen button voice prosthesis; these numbers were set as 100%. PBS causes an increase in airflow resistance of 31 Ϯ 9 cm H 2 O ⅐ s liter Ϫ1 ; this was set as 0.
a mixed fungal-bacterial biofilm on silicone rubber voice prostheses in the modified Robbins device (1) .
The influence of the biosurfactants tested in the airflow resistance of biofilms is summarized in Table 2 . The airflow resistance of the Groningen button voice prostheses used prior to biofilm formation was 66 Ϯ 7 cm H 2 O ⅐ s liter Ϫ1 (average Ϯ standard deviation) as averaged over all nine prostheses involved in this study. The airflow resistances of prostheses increased on average by 31 Ϯ 9 cm H 2 O ⅐ s liter Ϫ1 after 7 days of biofilm formation and perfusion of the artificial throats with PBS (control). Biosurfactants 1 and 2 both caused significant decreases (Student's t test, P Ͻ 0.05) in airflow resistance, 16 and 22 cm H 2 O ⅐ s liter Ϫ1 , respectively, compared with the values observed for the control. The decrease in airflow resistance also suggests that the integrity of the biofilm was affected. The density of biofilms on voice prostheses causes unwanted increases in airflow resistance, impeding speech, and is caused by extracellular polymeric substances (EPS) (4) . It has been suggested that it is not the thickness of biofilms that is the most important factor in valve failure but rather the combined presence of EPS-producing bacterial strains and fungal species (7). Elving et al. concluded that the persistence of biofilms on voice prostheses is determined not so much by the number of organisms in the biofilm as by the production of EPS that glue the biofilm together and increase the airflow resistance of voice prostheses. Apparently, it is more effective to decrease the viability of biofilms by acting directly on the EPS than to reduce the number of organisms on the esophageal surface of voice prostheses (8) .
The approach developed in this study is a promising strategy, as it was demonstrated that the adsorbed biosurfactants inhibit biofilm formation and the occurrence of increased airflow resistance. As a consequence, the useful lifespan of voice prostheses may be lengthened, an effect which would directly benefit laryngectomized patients. 
